OR
ORMP
Oramed Pharmaceuticals Inc. $4.66 1M +9.1% 3M +22.6% YTD +60.1% as of 2026-09-11↑↓ next ticker · ⌘+↑↓ or scroll to zoom · ←→ pan · 0 reset
▲ buy ▼ sell · size ≈ trade size · earnings ● beat ● miss · ring ◯ before open ◯ after close · ─ moving averages · click the buttons above to hide them
Model view — historical tendencies for the days ahead, not a forecast
Next 1 day
+1.0%
Next 1 week
+1.6%
Next 1 month
-0.6%
Seasonality
Weak window historically
Next 30 days (to Oct 14): -5.2% median,
33% of the last 18 years finished up.
20-year seasonality chart →
Mean reversion
Deeply oversold — RSI(2) at 5
RSI(2) under 15 is oversold (this name has historically bounced); over 85 is overbought.
Its dip-buy edge in history is +0.86%/day.
Mean-reversion stats →
1-month breakdown —
Market · β 1.10 -0.2% · Seasonal tilt -0.5%
$1M/day volume
56% volatility
+100% 1-year
-85% from ATH
52-week range · 76% of the way up · -15% from the high
$2.09$5.47
Congressional trades in ORMP Full tracker →
2 members · 1 buys / 3 sells · $18K–$95K disclosed · latest filing Feb 25, 2025.
| SELL | $15K–$50K | |
| SELL | $1K–$15K | |
| SELL | $1K–$15K | |
| BUY | $1K–$15K |
Earnings Full history →
Next report 2026-11-12 (Thursday, after close, in 59 days) · EPS est. 0.52.
1-day std dev
5.9%
Finished up
49%
Biggest pop
+19.2%
Biggest drop
-13.1%
Standard deviation of the close-to-close move over the last 47 reports. History, not a forecast.
Data from the U.S. House Clerk and FINRA, plus end-of-day prices. Not investment advice.